Deucravacitinib Remains Safe, Effective Through Week 52 in Psoriatic Arthritis

Andrew Blauvelt, MD, leads a roundtable discussion with Melinda Gooderham, MSc, MD, and Neil Korman, MD

Related Keywords

Portland ,Oregon ,United States ,Canada ,Melinda Gooderham ,Sandy Blauvelt ,Andrew Blauvelt ,Neil Korman ,Oregon Medical Research Center ,American College Of Rheumatology ,Case Western Reserve University In Cleveland ,American College ,Medpage Today ,Case Western Reserve University ,